MGX Board Reviews OpenAI and Isomorphic Investments Across Expanding AI Portfolio
Abu Dhabi's national AI investment company is widening its exposure from frontier models to drug discovery and infrastructure as contracted capacity in its portfolio moves toward 8 gigawatts.
H.H. Sheikh Tahnoon bin Zayed Al Nahyan, Deputy Ruler of Abu Dhabi and Chairman of MGX, chaired the company's second board meeting of 2026, reviewing new investments and performance across a portfolio that Abu Dhabi Media Office said continues to expand across the AI tech stack.
The board reviewed MGX's participation as co-lead in OpenAI's latest $122 billion funding round, its fifth follow-on investment in the company, and its participation in Isomorphic Labs' $2.1 billion Series B round, MGX's first move into AI-enabled drug discovery. The board also reviewed contracted capacity by MGX portfolio companies, which is projected to exceed 8 gigawatts by the end of 2026.
Ahmed Yahia Al Idrissi, chief executive officer and managing director of MGX, said the firm continues to invest across frontier models, platforms and the infrastructure required to scale them globally. The meeting was also attended by Khaldoon Khalifa Al Mubarak, Jassem Mohamed Bu Ataba Al Zaabi, Peng Xiao and Martin Edelman.
Email Edition
Receive The Emirates Intelligencer by email
Subscribe for the daily AI investment bulletin when the latest issue is published.